Apparatus and method for treating ventricular tachyarrhythmias

• US 7,522,956 B2
• Filed: 03/07/2005
• Issued: 04/21/2009
• Est. Priority Date: 04/30/1997
• Status: Expired due to Term

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Gilkerson, James O., Linder, William J., Krig, David B., Zimmer, William L., Dreher, Robert D., Wald, Jan D.
• Primary Examiner(s): EVANISKO, GEORGE ROBERT
• Application Number:
  US11/073,818
• Publication Number:
  US 20050149135A1
• Time in Patent Office: 1,506 Days
• Field of Search: 607/4, 607/5
• US Class Current: 607/4
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/395 for treating atrial fibrillation
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A system and method for selectively treating a ventricular tachycardia based on sensed atrial and ventricular intervals from the patient'"'"'s heart. A detection window of the ten most recent atrial and ventricular intervals are analyzed for the occurrence of either tachycardia or fibrillation. When a majority of the sensed intervals are satisfied, the apparatus starts a duration time interval. Ventricular intervals and atrial intervals are compare, ventricular interval greater than the atrial interval by a bias factor the system delivers tachycardia therapy to the heart. Alternatively, the method withholds tachycardia therapy to the heart when the atrial rate is classified as atrial fibrillation and the ventricular response is unstable.

Claims

1. An implantable cardioverter-defibrillator, comprising:

an atrial catheter including at least one atrial sensing electrode;

a ventricular catheter including at least one ventricular sensing electrode and at least one ventricular defibrillation electrode;

sensing circuitry, coupled to the atrial catheter and the ventricular catheter, the sensing circuitry adapted to sense atrial events and ventricular events from the electrodes;

therapy delivery circuitry, coupled to the ventricular catheter, the therapy delivery circuitry adapted to apply or inhibit a ventricular tachycardia therapy; and

control circuitry, coupled to the sensing circuitry and therapy circuitry, the control circuitry adapted to;

detect at least one of a ventricular tachycardia and a ventricular fibrillation by analyzing the sensed ventricular events;

start a first time interval when the at least one of the ventricular tachycardia and the ventricular fibrillation is detected;

analyze the sensed atrial and ventricular events during the first time interval for assessing an origin of the detected at least one of the ventricular tachycardia and the ventricular fibrillation;

determine whether to delay or inhibit the ventricular tachycardia therapy based on the origin of the detected at least one of the ventricular tachycardia and the ventricular fibrillation;

determine whether the detected at least one of the ventricular tachycardia and the ventricular fibrillation is sustained during the first time interval; and

reset the first time interval if the at least one of the ventricular tachycardia and the ventricular fibrillation does not sustain during the first time interval.

2. The implantable cardioverter-defibrillator of claim 1, wherein the control circuitry is adapted to:

determine an average atrial rate from the sensed atrial events;

determine an average ventricular rate from the sensed ventricular events; and

determine whether the average ventricular rate is not greater than the average atrial rate by at least a bias factor.

3. The implantable cardioverter-defibrillator of claim 2, wherein the therapy delivery circuitry is adapted to inhibit the ventricular tachycardia therapy if the average ventricular rate is not greater than the average atrial rate by at least the bias factor.

4. The system of claim 2, wherein the control circuitry is adapted to determine the first time interval using the ventricular rates.

5. The system of claim 4, wherein the first time interval is programmed to a length between 1 second and 60 seconds.

6. The implantable cardioverter-defibrillator of claim 1, wherein the control circuitry is adapted to determine whether an onset rate is gradual during the first time interval, wherein the onset rate is the rate of transition of a ventricular rate from a slower sinus rate to a tachycardia rate and the onset rate is gradual when the onset rate is equal to or greater than an onset threshold value.

7. The implantable cardioverter-defibrillator of claim 6, wherein the therapy delivery circuitry is adapted to inhibit the ventricular tachycardia therapy when the onset rate is gradual.

8. The implantable cardioverter-defibrillator of claim 1, wherein the control circuitry is adapted to determine whether the ventricular rate is unstable, wherein the ventricular rate is unstable when an average variance of ventricular intervals exceeds a stability interval threshold value.

9. The implantable cardioverter-defibrillator of claim 8, wherein the therapy delivery circuitry is adapted to inhibit the ventricular tachycardia therapy when the ventricular rate is unstable.

10. The implantable cardioverter-defibrillator of claim 8, wherein the control circuitry is adapted to determine an occurrence of atrial fibrillation from the sensed atrial events.

11. The implantable cardioverter-defibrillator of claim 10, wherein the therapy delivery circuitry is adapted to inhibit the ventricular tachycardia therapy if the ventricular rate is unstable and atrial fibrillation is occurring.

12. The system of claim 1, wherein the control circuitry is adapted to determine ventricular rates associated with the sensed ventricular events and detect the at least one of the ventricular tachycardia and the ventricular fibrillation using the ventricular rates.

13. The system of claim 12, wherein the control circuitry is adapted to compare the ventricular rates to a rate threshold to detect the at least one of the ventricular tachycardia and the ventricular fibrillation, and the at least one of the ventricular tachycardia and the ventricular fibrillation is detected when at least a first predetermined percentage of the ventricular rates exceed the rate threshold.

14. The system of claim 13, wherein the control circuitry is adapted to compare the ventricular rates to a rate threshold to determine whether the detected at least one of the ventricular tachycardia and the ventricular fibrillation is sustained, and the at least one of the ventricular tachycardia and the ventricular fibrillation is sustained when at least a second predetermined percentage of the ventricular rates exceed the rate threshold.

15. The system of claim 14, wherein the first predetermined percentage is between 65 and 95 percent, and the second predetermined percentage is between 45 and 75 percent.

16. The system of claim 15, wherein the first predetermined percentage is 80 percent, and the second predetermined percentage is 60 percent.

17. The system of claim 1, wherein the control circuitry is adapted to:

start a sustained rate duration upon expiration of the first time interval if the ventricular tachycardia therapy has been inhibited during the first time interval;

determine whether the detected at least one of the ventricular tachycardia and the ventricular fibrillation is sustained during the sustained rate duration; and

deliver the ventricular tachycardia therapy if the detected at least one of the ventricular tachycardia and the ventricular fibrillation is sustained during the sustained rate duration.

18. The system of claim 17, wherein the sustained rate duration is programmed to a value between 10 seconds and 60 minutes.